EUR 234.5
(0.51%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 3.17 Billion EUR | -0.86% |
2022 | 3.25 Billion EUR | 26.57% |
2021 | 2.57 Billion EUR | 258.0% |
2020 | 719 Million EUR | -65.58% |
2019 | 2.08 Billion EUR | 38.16% |
2018 | 1.51 Billion EUR | -9.62% |
2017 | 1.67 Billion EUR | 31.32% |
2016 | 1.27 Billion EUR | 4.86% |
2015 | 1.21 Billion EUR | 21.87% |
2014 | 997 Million EUR | 15.26% |
2013 | 865 Million EUR | 4.0% |
2012 | 831.71 Million EUR | 21.76% |
2011 | 683.09 Million EUR | 10.45% |
2010 | 618.47 Million EUR | 11.39% |
2009 | 555.21 Million EUR | 7.91% |
2008 | 514.53 Million EUR | 1.97% |
2007 | 504.58 Million EUR | 9.73% |
2006 | 459.85 Million EUR | 16.82% |
2005 | 393.63 Million EUR | -2.55% |
2004 | 403.94 Million EUR | 10.71% |
2003 | 364.85 Million EUR | 7.13% |
2002 | 340.58 Million EUR | 9.65% |
2001 | 310.59 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 1.94 Billion EUR | 0.0% |
2023 Q2 | 1.89 Billion EUR | 0.0% |
2023 Q4 | 1.4 Billion EUR | 0.0% |
2023 FY | 3.23 Billion EUR | -0.86% |
2022 Q4 | 1.45 Billion EUR | 0.0% |
2022 FY | 3.25 Billion EUR | 26.57% |
2022 Q2 | 1.78 Billion EUR | 0.0% |
2021 Q2 | 1.31 Billion EUR | 0.0% |
2021 Q4 | 1.2 Billion EUR | 0.0% |
2021 FY | 2.57 Billion EUR | 258.0% |
2020 Q4 | 957 Million EUR | 0.0% |
2020 Q2 | -238 Million EUR | 0.0% |
2020 FY | 719 Million EUR | -65.58% |
2019 Q4 | 962 Million EUR | 0.0% |
2019 Q2 | 1.12 Billion EUR | 0.0% |
2019 FY | 2.08 Billion EUR | 38.16% |
2018 Q4 | 542 Million EUR | 0.0% |
2018 FY | 1.51 Billion EUR | -9.62% |
2018 Q2 | 970 Million EUR | 0.0% |
2017 FY | 1.67 Billion EUR | 31.32% |
2017 Q2 | 671 Million EUR | 0.0% |
2017 Q4 | 1 Billion EUR | 0.0% |
2016 FY | 1.27 Billion EUR | 4.86% |
2016 Q2 | 652 Million EUR | 0.0% |
2016 Q4 | 622 Million EUR | 0.0% |
2015 Q2 | 623 Million EUR | 0.0% |
2015 FY | 1.21 Billion EUR | 21.87% |
2015 Q4 | 592 Million EUR | 0.0% |
2014 Q2 | 335 Million EUR | 0.0% |
2014 FY | 997 Million EUR | 15.26% |
2014 Q4 | 662 Million EUR | 0.0% |
2013 Q2 | 455 Million EUR | 0.0% |
2013 FY | 865 Million EUR | 4.0% |
2013 Q4 | 410 Million EUR | 0.0% |
2012 Q4 | 210.39 Million EUR | 0.0% |
2012 Q2 | 210.39 Million EUR | 0.0% |
2012 Q1 | 210.39 Million EUR | 19.25% |
2012 FY | 831.71 Million EUR | 21.76% |
2012 Q3 | 210.39 Million EUR | 0.0% |
2011 Q2 | 176.43 Million EUR | 0.0% |
2011 Q3 | 176.43 Million EUR | 0.0% |
2011 Q4 | 176.43 Million EUR | 0.0% |
2011 FY | 683.09 Million EUR | 10.45% |
2011 Q1 | 176.43 Million EUR | 7.53% |
2010 Q3 | 164.08 Million EUR | 0.0% |
2010 FY | 618.47 Million EUR | 11.39% |
2010 Q4 | 164.08 Million EUR | 0.0% |
2010 Q2 | 164.08 Million EUR | 0.0% |
2010 Q1 | 164.08 Million EUR | 15.57% |
2009 Q1 | 141.97 Million EUR | 9.58% |
2009 Q2 | 141.97 Million EUR | 0.0% |
2009 Q3 | 141.97 Million EUR | 0.0% |
2009 Q4 | 141.97 Million EUR | 0.0% |
2009 FY | 555.21 Million EUR | 7.91% |
2008 Q3 | 129.56 Million EUR | 0.0% |
2008 Q2 | 129.56 Million EUR | 0.0% |
2008 Q1 | 129.56 Million EUR | 2.05% |
2008 FY | 514.53 Million EUR | 1.97% |
2008 Q4 | 129.56 Million EUR | 0.0% |
2007 FY | 504.58 Million EUR | 9.73% |
2007 Q4 | 126.96 Million EUR | 0.0% |
2007 Q3 | 126.96 Million EUR | 0.0% |
2007 Q2 | 126.96 Million EUR | 0.0% |
2007 Q1 | 126.96 Million EUR | 9.11% |
2006 Q1 | 116.36 Million EUR | 14.01% |
2006 Q4 | 116.36 Million EUR | 0.0% |
2006 Q3 | 116.36 Million EUR | 0.0% |
2006 Q2 | 116.36 Million EUR | 0.0% |
2006 FY | 459.85 Million EUR | 16.82% |
2005 Q4 | 102.06 Million EUR | 0.0% |
2005 Q2 | 102.06 Million EUR | 0.0% |
2005 FY | 393.63 Million EUR | -2.55% |
2005 Q1 | 102.06 Million EUR | 1.06% |
2005 Q3 | 102.06 Million EUR | 0.0% |
2004 FY | 403.94 Million EUR | 10.71% |
2004 Q3 | 100.98 Million EUR | 0.0% |
2004 Q1 | 100.98 Million EUR | 10.71% |
2004 Q2 | 100.98 Million EUR | 0.0% |
2004 Q4 | 100.98 Million EUR | 0.0% |
2003 Q1 | 91.21 Million EUR | 7.13% |
2003 Q4 | 91.21 Million EUR | 0.0% |
2003 FY | 364.85 Million EUR | 7.13% |
2003 Q3 | 91.21 Million EUR | 0.0% |
2003 Q2 | 91.21 Million EUR | 0.0% |
2002 Q3 | 85.14 Million EUR | 0.0% |
2002 FY | 340.58 Million EUR | 9.65% |
2002 Q2 | 85.14 Million EUR | 0.0% |
2002 Q1 | 85.14 Million EUR | 9.65% |
2002 Q4 | 85.14 Million EUR | 0.0% |
2001 FY | 310.59 Million EUR | 0.0% |
2001 Q3 | 77.64 Million EUR | 0.0% |
2001 Q2 | 77.64 Million EUR | 0.0% |
2001 Q1 | 77.64 Million EUR | 0.0% |
2001 Q4 | 77.64 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Crossject Société Anonyme | -11.8 Million EUR | 27015.254% |
Safe Orthopaedics SA | -5.96 Million EUR | 53370.715% |
Spineway SA | -9.03 Million EUR | 35256.077% |
Amplitude Surgical SA | 13.24 Million EUR | -23886.104% |
Sartorius Stedim Biotech S.A. | 484.5 Million EUR | -555.521% |
bonyf N.V. | -39.89 Thousand EUR | 7961178.947% |